Clinical trial

Speech-based Assessment of Relapse Risk in People With Psychosis

NCT07397975

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-01-29

PhaseN/A

Study timeline

Study start (actual)2026-01-29Date precision: day

Registry last updated2026-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychotic Disorderunresolved

Interventions

Weekly online speech assessments via a smartphone app collect speech and self-report data. Recordings are securely transferred and analyzed by an AI-based backend to calculate relapse risk scores.OTHER

Sponsors & collaborators

Philipp Homanlead sponsor

Mapped research locations

GroningenNetherlands1 ZurichSwitzerland1 IzmirTurkey (Türkiye)1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07397975 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.